Too many white cells—TAM, JMML, or something else?
Authors:
- 8 December 2023
- journal article
- research article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2023 (1) , 37-42
Abstract
Leukocytosis is a common finding in pediatric patients, and the differential diagnosis can be broad, including benign reactive leukocytosis and malignant myeloproliferative disorders. Transient abnormal myelopoiesis is a myeloproliferative disorder that occurs in young infants with constitutional trisomy 21 and somatic GATA1 mutations. Most patients are observed, but outcomes span the spectrum from spontaneous resolution to life-threatening complications. Juvenile myelomonocytic leukemia is a highly aggressive myeloproliferative disorder associated with altered RAS-pathway signaling that occurs in infants and young children. Treatment typically involves hematopoietic stem cell transplantation, but certain patients can be observed. Early recognition of these and other myeloproliferative disorders is important and requires a clinician to be aware of these diagnoses and have a clear understanding of their presentations. This paper discusses the presentation and evaluation of leukocytosis when myeloproliferative disorders are part of the differential and reviews different concepts regarding treatment strategies.Keywords
This publication has 44 references indexed in Scilit:
- Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971Blood, 2011
- Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemiaBlood, 2011
- Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemiaBritish Journal of Haematology, 2011
- Heterozygous Germline Mutations in the CBL Tumor-Suppressor Gene Cause a Noonan Syndrome-like PhenotypeThe American Journal of Human Genetics, 2010
- Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemiaJournal of Medical Genetics, 2010
- Morphologic Differential Diagnosis of Juvenile Myelomonocytic Leukemia—Pitfalls Apart From Viral InfectionJournal of Pediatric Hematology/Oncology, 2009
- Treatment and prognostic impact of transient leukemia in neonates with Down syndromeBlood, 2008
- Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AMLLeukemia, 2007
- A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481Blood, 2006
- Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndromeNature Genetics, 2002